$ALLO: Nasdaq Welcomes Allogene Therapeutics, Inc. (Nasdaq: ALLO) To …

Date: Friday, October 12th, 2018

Stock(s) mentioned:

Source: Benzinga (https://www.benzinga.com)

Summary: NEW YORK, Oct. 12, 2018 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (NASDAQ:ALLO), a clinical-stage biotechnology company pioneering the …

Full article address: https://www.benzinga.com/pressreleases/18/10/g12500508/nasdaq-welcomes-allogene-therapeutics-inc-nasdaq-allo-to-the-nasdaq-st

Related News:

$ALLO: Allogene closes $373M IPO

$PLAN $ALLO: US IPO Weekly Recap: Despite Sell-Off, 4 IPOs Price With Unicorn …

$ALLO $MUR: 44 Biggest Movers From Yesterday

$ALLO: Why a Peninsula cancer fighter soared nearly 40% after record …

$ALLO: Allogene increases IPO to 18M shares, trading kicks off today

Latest News:

$MS: The Wall Street Journal: Morgan Stanley banker’s side gig could help firm land highly coveted role in Uber IPO

$YMZ8 $ESZ8 $NQZ8 $SPX $DJIA $COMP: Need to Know: Analyst who predicted the 2008 crash, warns of bubble brewing in U.S. household wealth

$CSIQ: Canadian Solar Partners with Biosar to Build a 256 MWp of Solar …

$LMNX: Luminex to acquire MilliporeSigma’s flow cytometry business for $75M

$LOAN: Manhattan Bridge Capital, Inc. Reports Third Quarter Results

$AXSM: Axsome Therapeutics Hosts R&D Day Today with Key Opinion …

$HYGS: Hydrogenics Announces Third Quarter Conference Call on …

$GLOG: GasLog Ltd. Announces Date For Third Quarter 2018 Results …

$POOL: Pool Corporation Reports Record Third Quarter Results

$AGIO: Agios to Webcast Conference Call of Third Quarter 2018 Financial …

$FIXX: Homology Medicines Presents Long-Term Efficacy Data of a Single …